{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicklkldbztmcmaf7jg25gl6z5n7shlo6bu3pdvbjvug7nhezmoz7y",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mhhzt6my2at2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreif6swh33vc7sgbj3aqpacgiunukpslno5i4lco4jvy53zhrqtksb4"
    },
    "mimeType": "image/jpeg",
    "size": 71534
  },
  "path": "/2026/03/19/wegovy-novo-norisk-high-dose-approved/?utm_campaign=rss",
  "publishedAt": "2026-03-19T16:21:12.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "biotechnology",
    "Eli Lilly",
    "Novo Nordisk",
    "Obesity",
    "Pharmaceuticals",
    "STAT+",
    "weight loss"
  ],
  "textContent": "A high-dose version of Novo Nordisk’s injectable obesity drug Wegovy received U.S. approval.",
  "title": "STAT+: Novo Nordisk’s high-dose Wegovy approved in the U.S.",
  "updatedAt": "2026-03-19T16:39:44.000Z"
}